1

Partington, Mr Michael  (NSW)  (PDF 8KB)

2

Sutherland, Dr G K  (NSW)  (PDF 229KB)

3

Ronan, Dr Anne  (NSW)  (PDF 43KB)

4

Centre for Governance of Knowledge and Development (Dr Luigi Palombi)  (ACT) Part 1 (PDF 1230KB) Part 2 (PDF 4524KB) Response to question on notice arising from hearing 19.3.09, dated 2.4.09 (PDF 244KB) and received 6.5.09 (PDF 187KB)  Presentation at hearing 14.9.09 (PDF 6520KB)

5

Lawson, Dr Charles  (QLD)  (PDF 649KB)

6

Winfield, Ms Bee  (WA)  (PDF 35KB)

7

Australian Medical Association (AMA)  (ACT)  (PDF 61KB)

8

Hamblin, Dr John  (WA)  (PDF 75KB)

9

Kirk, A/Professor Judy  (NSW)  (PDF 150KB)

10

Such MP, The Hon Bob   (SA)  (PDF 397KB)

11

Haskell, Professor Dennis and Ms Rhonda  (WA)  (PDF 301KB)

12

National Health and Medical Research Council  (ACT)  (PDF 453KB)  Response to questions concerning SCNIA gene and its association with Dravet syndrome, dated 23.4.09 (PDF 6409KB)

13

Wahlstrom, Emertius Professor Jan  (SWEDEN)  (PDF 74KB)

14

Western Australian Government  (WA)  (PDF 1509KB)

15

Willcox, Professor Mark  (NSW)  (PDF 95KB)

16

South Australian Government  (SA)  (PDF 634KB)

17

Sarnoff, Professor Joshua D
Kahn, A/Professor Jonathan
Andrews, Professor Lori B  (USA)  (PDF 283KB)  Att1 (PDF 299KB) Supplementary submission received 24.4.09  (PDF 78KB)

18

Australian Law Reform Commission  (NSW)  (PDF 127KB)

19

Department of Innovation Industry, Science and Research and IP Australia  (ACT)  (PDF 514KB) 
Response to questions arising from the preliminary briefing 19.3.09, dated 4.6.09  (PDF 41KB) 
Response to question regarding exclusions from patentability under TRIPS AND AUSFTA, dated 29.7.09  (PDF 19KB) 
'Estimating the Patent Premium: Evidence from the Australian Inventor Survey', P.H. Jensen, R. Thomson and J.Yong, May 2009, received 7.8.09  (PDF 486KB)
Patent No. 13,427/23 application dated 19 July 1923, provided at hearing 20.9.09 (PDF 3198KB) 
Patent No. 11.047/19 application dated 8 May 1919, provided at hearing 20.9.09 (PDF 1311KB)
Response to question on notice arising from hearing 20.8.09, received 31.8.09 (PDF 21KB) 
Clarification of evidence relating to the 202 Australian patents, dated 7.9.09  (PDF 42KB) 
Response to a question arising from the hearing 20.8.09 regarding ALRC recommendations, dated 7.9.09   (PDF 33KB) 
Response to question on notice arising from hearing 20.8.09, received 7.9.09  (PDF 15KB) 
Supplementary submission dated 30.9.09  (PDF 290KB)
IP response to Senator the Hon Heffernan's submission no 76 (PDF 175KB)
Correction to IP response to Senator the Hon Heffernan's submission no 76 (PDF 28KB)
Clarification of evidence from hearing 18.05.10, received 07.06.10 (PDF 125KB)
Timeframes of ACIP Review and IP Australia's IP Reform Project, tabled at public hearing 15.06.10 (PDF 247KB)
Response to questions on notice arising from public hearing 15.06.10, received 30.07.10 (PDF 1815KB)

21

Medicines Australia  (ACT)  (PDF 46KB)  Response to question on notice dated 25.9.09  (PDF 1254KB)

22

Hawkins, Ms Naomi  (UK)  (PDF 93KB)

23

Nicol, Professor Dianne and Nielsen, Dr Jane  (TAS)  (PDF 99KB) Response to questions concerning patent pooling arrangements arising from the hearing 3.8.09, received 31.08.09  (PDF 4KB)

24

Genetic Technologies Limited  (VIC)  (PDF 40KB)  Additional information received 31.3.09 (PDF 233KB)

25

Bath, Mr David  (PDF 112KB)

26

Walter and Eliza Hall Institute of Medical Research  (VIC)  (PDF 4881KB)  Response to question arising from hearing 3.8.09, received 3.8.09  (PDF 85KB)

27

Davies Collison Cave  (VIC)  (PDF 520KB)

28

Peter MacCallum Cancer Centre  (VIC)  (PDF 37KB)

29

Biotechnology Industry Organization (BIO)  (USA)  (PDF 2012KB)

30

Breast Cancer Action Group NSW  (NSW)  (PDF 540KB)

31

Institute of Patent and Trade Mark Attorneys of Australia (IPTA)  (VIC)  (PDF 392KB)  Supplementary submission dated 7.9.09  (PDF 219KB)
Supplementary submission received 06.08.10 (PDF 277KB)

32

Office of the Gene Technology Regulator  (ACT)  (PDF 1049KB)

33

Human Genetics Society of Australasia  (VIC)  (PDF 65KB)  Att1 (PDF 94KB)  Att2 (PDF 52KB)

34

FB Rice & Co  (VIC)  (PDF 190KB)

35

Country Women's Association of NSW  (NSW)  (PDF 57KB)

36

The Intellectual Property Research Institute of Australia (IPRIA)  (VIC)  (PDF 502KB)  'An Empirical Investigation into Patent Enforcement in Australian Courts', K. Weatherall and P.H. Jensen, received 3.8.09  (PDF 3235KB)

37

Swedish National Council on Medical Ethics  (SWEDEN)  (PDF 23KB)

38

Christie, Professor Andrew  (VIC)  (PDF 104KB)
Response to question taken on notice arising from public hearing 04.08.09, received 02.10.09 (PDF 90KB)

39

Leary, Professor Jennifer  (NSW)  (PDF 88KB)

40

National Coalition of Public Pathology  (ACT)  (PDF 161KB)

41

Royal Australasian College of Surgeons  (VIC)  (PDF 22KB)

42

George, Ms Anna  (PDF 79KB)

43

Medical Technology Association of Australia  (NSW)  (PDF 49KB)

44

Johnson & Johnson Family of Companies Australia  (NSW)  (PDF 257KB)

45

Rimmer, Dr Matthew  (ACT)  (PDF 34KB)
Additional information relating to a US lawsuit which argues that patents on two human genes associated with breast and ovarian cancer are unconstitutional and invalid, received 13.05.09 (PDF 47KB)
Additional information arising from public hearing 20.08.09, received 21.08.09 (PDF 55KB)

46

Saul, Dr Ben  (NSW)  (PDF 49KB)

47

Cancer Voices NSW  (NSW)  (PDF 502KB)
Opening Statement from hearing 05.08.10 (PDF 10KB)
Response to Senator the Hon Heffernan's submission no 76 (PDF 720KB)

48

Breast Cancer Network Australia  (VIC)  (PDF 83KB)
'The key issues for BCNA's members', tabled at hearing 03.08.10 (PDF 229KB)
Response to Senator the Hon Heffernan's submission no 76 (PDF 1382KB)

49

Royal College of Pathologists of Australasia  (NSW)  (PDF 517KB)  'Report of the Australian Genetic Testing Survey 2006', Royal College of Pathologists of Australasia  (PDF 177KB) and 'Genetic Testing in the 21^st Century: Are we ready?', Royal College of Pathologists of Australasia  (PDF 85KB) received following hearing 3.8.09, Clarification of evidence provided at hearing 4.08.09 (PDF 124KB)  "The Supreme Court, Process Patents, and Medical Innovation',  A. Kesselheim, New England Medical Journal; 361:24  (PDF 159KB)   'Who Owns Science? The Manchester Manifesto', University of Manchester, Institute for Science Ethics and Innovation, November 2009  (PDF 386KB)
Meeting summary of Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) October 8-9 2009, received 20.10.09 (PDF 36KB)
Presentation from the Chair of the US Secretary's Advisory on Genetics, Health and Society, received 16.10.09 (PDF 110KB)

50

Cancer Council Australia  (NSW)  (PDF 104KB) Additional information received 18.08.09 (PDF 120KB)  Correspondence clarifying the Council's position on evidence received dated 15.12.09  (PDF 656KB)
Response to Senator the Hon Heffernan's submission no 76 (PDF 69KB)
Letter to Senator the Hon Humphries tabled at Public Hearing 18 May 2010 (PDF 262KB)

51

Pfizer Australia  (NSW)  (PDF 624KB)  Additional information commenting on a ban on gene patenting, dated 30.4.09 (PDF 746KB)

52

Australian Marfan Foundation  (SA)  (PDF 106KB) Additional information dated 10.08.09 (PDF 2084KB)

53

Tasmanian Government  (TAS)  (PDF 44KB)

54

New South Wales Government   (NSW)  (PDF 42KB)

55

Coyte, Dr Belinda  (SA)  (PDF 42KB)
Additional information concerning gene testing, received 19.08.09 (PDF 10KB)

56

Carey, Ms Trish  (SA)  (PDF 7KB)

58

Royal Australian and New Zealand College of Obstetricians and Gynaecologists  (VIC) (PDF 165KB)

59

Johnston, Mr Adam  (NSW)  (PDF 6KB)

62

Department of Health and Ageing  (ACT)  (PDF 40KB)

63

MADGE  (VIC)  (PDF 77KB)

64

Wylie, Ms Alison  (WA)  (PDF 5KB)

65

Ninham, Ms Veronica  (PDF 4KB)

66

Skippings, Ms Tracy  (PDF 6KB)

67

Campbell, Dr M  (PDF 204KB)

69

Parke MP, Ms Melissa (WA)  (PDF 301KB)

70

Xenome Limited  (PDF 1205KB)

73

Bourne, Mr Paul  (PDF 4KB)

74

Chartered Institute of Patent Attorney's (CIPA)  (PDF 280KB)

75

AusBiotech  (PDF 22KB)